Astrocyte Pharmaceuticals, AST-004, Series B Financing, Traumatic Brain Injury, TBI, Concussion, Sports-Related Concussion, Phase 2 Clinical Trial

GROTON, Connecticut, September 30, 2026 Astrocyte Pharmaceuticals Inc. has secured $9.5 million in Series B financing to advance the...